Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
516.00
Ask:
520.00
Spread: 4.00 (0.775%)
Market Cap: £860.42m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Pre-close Statement

9 Jul 2013 07:00

RNS Number : 8583I
Oakley Capital Investments Limited
09 July 2013
 



9 July 2013

 

Oakley Capital Investments Limited ("OCIL" or the "Company")

 

Pre-close Statement

 

·; NAV (unaudited) expected to be in the range of £1.93 - £1.95, an increase of at least 11% over the last 12 months

 

Oakley Capital Investments Limited (AIM: OCL), the AIM-listed company established to provide investors with access to the investment strategy being pursued by Oakley Capital Private Equity L.P. (the "Limited Partnership" or the "Fund"), announces its pre-close statement for the 6 months ended 30 June 2013.

 

The Company, through its investment in the Limited Partnership, has an indirect interest in each of the Limited Partnership's portfolio companies representing 65% of the Limited Partnership's total commitments.

 

To-date the Limited Partnership has exited four of its portfolio investments achieving a gross money multiple on its cost of investment of 2.6x and IRR of 43%, and returning £109m to the Company. In aggregate across all the disposals to-date, the Limited Partnership has achieved a 14% uplift in realisation proceeds above the previous book value of the relevant investment.

 

The Limited Partnership's portfolio of remaining investments comprises six businesses; Daisy Group plc; Verivox Holdings Limited; Time Out Group (Time Out Limited and Time Out America LLC); Intergenia; Broadstone Pensions and Investments Limited; and Monument Securities Limited. Oakley Capital Limited, OCIL's investment adviser, estimates that the Company's net asset value per share will be in the range of £1.93 - £1.95 (31 December 2012: £1.81) (30 June 2012: £1.74). The OCIL net asset value is made up of cash, the investment in the Limited Partnership and loans provided to the Limited Partnership and a number of the portfolio companies.

 

 

Peter Dubens, Director, commented:

 

"We have had a strong start to 2013 with three exits which have generated attractive returns for the Company.

 

We continue to see strong deal flow and have a number of new investment and portfolio company bolt-on acquisitions under review."

 

 

For further information please contact:

 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens

 

FTI Consulting

+44 20 7831 3113

Edward Bridges / Emily Hartman

 

Liberum Capital Limited (Financial Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Tom Fyson

 

 

About Oakley Capital Investments Limited ("OCIL")

Oakley Capital Investments Limited is a Bermudian incorporated company listed on AIM. OCIL seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P. and, over time, through co-investment opportunities.

 

 

About Oakley Capital Private Equity L.P. (the "Fund")

Oakley Capital Private Equity L.P., a Bermuda established limited partnership, is an unlisted UK and European mid-market private equity fund with the aim of providing investors with significant long term capital appreciation. The Fund's investment strategy is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. The Fund seeks to invest in businesses with scale in their industry subsectors, thereby creating a sustainable earnings stream which should command a premium on exit.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUUPMUPWPUR
Date   Source Headline
27th Jan 20215:06 pmRNSDirector Dealing
27th Jan 20217:00 amRNSTrading update for the year ended 31 December 2020
26th Jan 20217:00 amRNSInvestment in idealista
7th Jan 20217:00 amRNSSale of the DWS division of the Daisy Group
22nd Dec 20204:11 pmRNSHolding(s) in Company
11th Dec 20202:33 pmRNSDirector Declaration
4th Dec 20203:58 pmRNSHolding(s) in Company
3rd Dec 20204:50 pmEQSHardman & Co Research: Oakley Capital Investments (OCI): NAV: conservative, robust and with growth upside
3rd Dec 20201:52 pmRNSTransaction in Own Shares
25th Nov 20207:00 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSDirector/PDMR Shareholding
22nd Oct 20207:00 amRNSAcquisition of WindStar Medical
6th Oct 202012:42 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSTransaction in Own Shares (Amendment)
2nd Oct 20204:33 pmRNSTransaction in Own Shares
2nd Oct 20207:00 amRNSShare Buy-Back Programme
1st Oct 20207:00 amRNSAcquisition of 7NXT
30th Sep 20201:54 pmRNSAppointment of Non-Executive Director
17th Sep 20207:00 amRNSOakley sells Casa.it to EQT
10th Sep 20207:00 amRNSResults for the six months ended 30 June 2020
1st Sep 20207:20 amEQSHardman & Co Research: Oakley Capital Investments (OCI) - initiation of coverage: 'When it rains gold, put out the bucket'
4th Aug 20203:09 pmRNSHolding(s) in Company
29th Jul 20206:15 pmRNSTransaction in Own Shares
29th Jul 20207:00 amRNSTrading update for the six months ended 30 June 20
15th Jul 20209:30 amRNSKepler Trust Intelligence: New Research
6th Jul 20207:00 amRNSCapital Commitment
30th Jun 20207:00 amRNSDirectorate Change
24th Jun 20206:02 pmRNSDirector Dealing
22nd Jun 202012:22 pmRNSHolding(s) in Company
19th Jun 20205:38 pmRNSDirector Dealing
19th Jun 20207:01 amRNSDirector Dealing
19th Jun 20207:00 amRNSDirector Dealing
18th Jun 20205:57 pmRNSHolding(s) in Company
18th Jun 20204:42 pmRNSTransaction in Own Shares
18th Jun 20207:00 amRNSShare Buy-Back
1st Jun 20202:25 pmRNSDirector Declaration
27th May 20205:01 pmRNSHolding(s) in Company
27th May 20207:00 amRNSResult of Annual General Meeting
22nd May 20204:33 pmRNSTime Out equity fundraise and OCI loan repayment
19th May 20207:00 amRNSDirector Declaration
7th May 20207:00 amRNSDirectorate Change and Total Voting Rights
1st May 20207:00 amRNSNotice of Annual General Meeting
8th Apr 20207:00 amRNSOakley completes sale of investment in Inspired
25th Mar 20207:00 amRNSCOVID-19 Update
20th Mar 20207:00 amRNSAnnual Report and Accounts 2019
18th Mar 20204:22 pmRNSTransaction in own Shares
18th Mar 20207:00 amRNSShare Buy-Back
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
12th Mar 20207:33 amRNSResults analysis from Kepler Trust Intelligence

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.